IBL Tool - Digitale Bibliotheek

Digitale Bibliotheek

Sluiten

Tijdschrift beschrijving

Alle jaargangen van het bijbehorende tijdschrift

Alle afleveringen van het bijbehorende jaargang

Alle artikelen van de bijbehorende aflevering

40 gevonden resultaten

nr	titel	auteur	tijdschrift	jaar	jaarg.	afl.	pagina('s)	type
1	ABPI publishes details of industry payments to health professionals			2016	757	1	p. 34	artikel
2	Affordability of new vaccinations challenging in Zambia			2016	757	1	p. 3	artikel
3	Anticoagulation self-monitoring favourable in the Netherlands			2016	757	1	p. 4	artikel
4	ART at any CD4 cell count cost effective in sub-Sahara			2016	757	1	p. 5	artikel
5	Biological DMARDs not cost effective for RA in Finland			2016	757	1	p. 6	artikel
6	Catch-up hepatitis A vaccination not cost effective in US			2016	757	1	p. 7	artikel
7	Cost analyses of PrePex device for VMMC			2016	757	1	p. 8	artikel
8	Costs of stroke substantial in indigenous Australians			2016	757	1	p. 9	artikel
9	Criteria for using expert judgement in economic studies			2016	757	1	p. 10	artikel
10	Delays in generic atorvastatin leave patients out of pocket			2016	757	1	p. 11	artikel
11	Drones offer promise for vaccine transport			2016	757	1	p. 12	artikel
12	Eltrombopag "dominated" romiplostim for thrombocytopenia			2016	757	1	p. 13	artikel
13	English patients set to benefit from accessing their online GP records			2016	757	1	p. 35	artikel
14	Estimates of osteoarthritis costs vary with costing methods			2016	757	1	p. 14	artikel
15	European HTA agencies require robust evidence in oncology			2016	757	1	p. 15	artikel
16	HOPE for home-based HIV testing: cost effective in Kenya			2016	757	1	p. 16	artikel
17	ICER posts draft scoping document for RRMS therapies			2016	757	1	p. 1	artikel
18	ICER to review drugs for RA (and psoriatic arthritis?)			2016	757	1	p. 2	artikel
19	Increased out-of-pocket spending in Europe since recession			2016	757	1	p. 17	artikel
20	Lack of access to TT immunisation is costly in Mozambique			2016	757	1	p. 18	artikel
21	Many stopping and restarting statins in UK			2016	757	1	p. 19	artikel
22	NICE draft guidance extends eligibility for certolizumab pegol			2016	757	1	p. 36	artikel
23	NICE: first drug approved from old Cancer Drugs Fund			2016	757	1	p. 37	artikel
24	Nivolumab not cost effective for non-squamous NSCLC			2016	757	1	p. 20	artikel
25	Non-invasive testing for Down's syndrome saves costs			2016	757	1	p. 21	artikel
26	Out-of-pocket costs in commercially insured adults varies			2016	757	1	p. 22	artikel
27	PBHCI grant may reduce costs for serious mental illness			2016	757	1	p. 23	artikel
28	PCV-13 has greatest benefit but not cost effective in China			2016	757	1	p. 24	artikel
29	PET-CT not justified for resectable colorectal cancer liver metastases			2016	757	1	p. 25	artikel
30	PHARMAC to change the way it makes decisions			2016	757	1	p. 38	artikel
31	PrEP during pregnancy cost effective in sub-Saharan Africa			2016	757	1	p. 26	artikel
32	Rescheduling of alprazolam reduces use and misuse			2016	757	1	p. 27	artikel
33	RRSO cost effective at ≥4% risk of ovarian cancer			2016	757	1	p. 28	artikel
34	SMC recommends five new treatments			2016	757	1	p. 39	artikel
35	STOPP/START criteria reduce ADRs and drug costs in elderly			2016	757	1	p. 29	artikel
36	Switzerland to resume drug pricing controls			2016	757	1	p. 40	artikel
37	Three-drug DAA regimen cost effective for HCV in HIV patients			2016	757	1	p. 30	artikel
38	Tocilizumab monotherapy cost effective for RA in Italy			2016	757	1	p. 31	artikel
39	Unrestricted access to HCV treatment cost effective in US			2016	757	1	p. 32	artikel
40	Wealthiest Americans have highest healthcare expenditure			2016	757	1	p. 33	artikel

40 gevonden resultaten

Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland